New rapid test could speed up care for severe postpartum bleeding
NCT ID NCT06255002
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 31 times
Summary
This study tested a new rapid bedside device (qLabs®FIB) that measures a key blood clotting protein called fibrinogen in women with severe bleeding after childbirth. The goal was to see if the quick test gives results as accurate as the standard lab test, which takes longer. 70 women participated, and the findings could help doctors make faster treatment decisions during emergencies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Cochin Maternité Port Royal
Paris, 75014, France
-
Hôpital Necker-Enfants Malades
Paris, 75015, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.